Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Mise à jour : Il y a 4 ans
Référence : NCT01276106

Femme et Homme

Extrait

This is a 24-week randomized placebo-controlled study to investigate the effect of an oral IL-1beta inhibitor AC-201 in patients with type 2 diabetes mellitus already treated on different background diabetes therapies.


Critère d'inclusion

  • Type 2 diabetes mellitus

Liens